Tissue microarray sampling strategy for prostate cancer biomarker analysis

MA Rubin, R Dunn, M Strawderman… - The American journal of …, 2002 - journals.lww.com
High-density tissue microarrays (TMA) are useful for profiling protein expression in a large
number of samples but their use for clinical biomarker studies may be limited in …

Tissue microarrays (TMAs) for high‐throughput molecular pathology research

A Nocito, J Kononen, OP Kallioniemi… - International journal of …, 2001 - Wiley Online Library
A rapidly increasing number of genes are being suspected to play a role in cancer biology.
To evaluate the clinical significance of newly detected potential cancer genes, it is usually …

Tissue microarrays in clinical oncology

D Voduc, C Kenney, TO Nielsen - Seminars in radiation oncology, 2008 - Elsevier
Tissue microarray (TMA) is a recently implemented, high-throughput technology for the
analysis of molecular markers in oncology. This research tool permits the rapid assessment …

Tissue microarrays for rapid linking of molecular changes to clinical endpoints

J Torhorst, C Bucher, J Kononen, P Haas… - The American journal of …, 2001 - Elsevier
Advances in genomics and proteomics are dramatically increasing the need to evaluate
large numbers of molecular targets for their diagnostic, predictive or prognostic value in …

Tissue microarray: a simple technology that has revolutionized research in pathology

S Avninder, K Ylaya, SM Hewitt - Journal of postgraduate …, 2008 - journals.lww.com
Tissue microarray (TMA) technology is a high-throughput research tool, which has greatly
facilitated and accelerated tissue analyses by in-situ technologies. TMAs are amenable to …

Tissue microarray (TMA) technology: miniaturized pathology archives for high‐throughput in situ studies

L Bubendorf, A Nocito, H Moch… - The Journal of …, 2001 - Wiley Online Library
Tissue microarray (TMA) technology allows a massive acceleration of studies correlating
molecular in situ findings with clinico‐pathological information. In this technique, cylindrical …

Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer

DR Rhodes, MG Sanda, AP Otte… - Journal of the …, 2003 - academic.oup.com
Background: Molecular signatures in cancer tissue may be useful for diagnosis and are
associated with survival. We used results from high-density tissue microarrays (TMAs) to …

Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues

AS Merseburger, MA Kuczyk, J Serth… - Oncology …, 2003 - spandidos-publications.com
Several investigators have reported the correlation of p53 and bcl-2 immunoreactivity with
post operative prostate specific antigen (PSA) recurrence. Focal and or clustered expression …

Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays

CL Liu, W Prapong, Y Natkunam, A Alizadeh… - The American journal of …, 2002 - Elsevier
The creation of tissue microarrays (TMAs) allows for the rapid immunohistochemical
analysis of thousands of tissue samples, with numerous different antibodies per sample …

Tissue microarrays: a current medical research tool

IS Shergill, NK Shergill, M Arya… - Current medical research …, 2004 - Taylor & Francis
Recent research in molecular biology has identified a significant number of novel markers,
which may have diagnostic, prognostic and therapeutic significance. This is particularly …